MedLab Clinical is a medical research and development facility researching and formulating novel bio-therapeutics (e.g. nutraceuticals and pharmaceuticals) to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease ad pre-diabetes/obesity.
There are 5 core research programs that are at various stages of investigation, Medlab Clinical researchers believe that the company is at the forefront of new bio-therapeutic discoveries, and, as such posits to progress its laboratory and clinical research that can bridge unmet needs in the ever increasing global trends in chronic diseases.
Why chronic diseases…?
“The global epidemic of chronic diseases that are associated with obesity and its disease correlated sequelae leads to an ever increasing cost to the community. Therefore biomedical research that is focused on improving the health of the community is of paramount importance. Global population trends in chronic disease prevalence are reporting increasing numbers of patients diagnosed with various chronic diseases and an acceleration in disease severity. Medlab Clinical is dedicated to develop novel therapeutic intervention that would improve chronic disease health outcomes, whether these be in prevention, maintenance support, or curative.”
To view the Medlab products available via the MCMP, please log in to: